phenytoin and sb 202190

phenytoin has been researched along with sb 202190 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Chen, Y; Wang, C; Xiao, X; Xu, G; Zhao, Y; Zhou, X	1

Other Studies

2 other study(ies) available for phenytoin and sb 202190

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells. Medical science monitor : international medical journal of experimental and clinical research, 2012, Volume: 18, Issue:10 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Humans; Imidazoles; K562 Cells; Leukemia; p38 Mitogen-Activated Protein Kinases; Phenytoin; Protein Kinase Inhibitors; Pyridines	2012

Article

Year

Chemical genetics reveals a complex functional ground state of neural stem cells.

Nature chemical biology, 2007, Volume: 3, Issue:5

Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007

Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells.

Medical science monitor : international medical journal of experimental and clinical research, 2012, Volume: 18, Issue:10

Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Humans; Imidazoles; K562 Cells; Leukemia; p38 Mitogen-Activated Protein Kinases; Phenytoin; Protein Kinase Inhibitors; Pyridines

2012